Blood 8-hydroxy-2′-deoxyguanosine is associated with erythropoietin resistance in haemodialysis patients

Nephrology Dialysis Transplantation

Volumn 18, Issue 5, 2003, Pages 931-936

  Kato, Akihiko ^a   Odamaki, Mari ^b   Hishida, Akira ^c  

^a SHIZUOKA CANCER CENTER   (Japan)

^b UNIVERSITY OF SHIZUOKA   (Japan)

^c HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

8 OhdG; Anaemia; Erythropoietin; Haemodialysis; MDA

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; HEMOGLOBIN; IRON SACCHARATE; RECOMBINANT ERYTHROPOIETIN;

ADULT; AGE; AGED; ANEMIA; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; CORRELATION ANALYSIS; DIABETES MELLITUS; DISEASE SEVERITY; FEMALE; HEMODIALYSIS; HEMOGLOBIN DETERMINATION; HUMAN; INFLAMMATION; KIDNEY FAILURE; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; NUTRITIONAL PARAMETERS; PRIORITY JOURNAL;

AGED; ANEMIA; CROSS-SECTIONAL STUDIES; DEOXYGUANOSINE; DRUG RESISTANCE; ERYTHROPOIETIN, RECOMBINANT; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; OXIDATION-REDUCTION; OXIDATIVE STRESS; RENAL DIALYSIS;

EID: 0038702033     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/gfg070     Document Type: Article

References (24)

1. Kaysen GA. Inflammation and oxidative stress in end-stage renal disease. Adv Nephrol 2000; 30: 201-214
2. Sommerburg O, Grune T, Hampl H et al. Does long-term treatment of renal anaemia with recombinant erythropoietin influence oxidative stress in haemodialysed patients? Nephrol Dial Transplant 1998; 13: 2583-2587
3. Ludat K, Sommerburg O, Grune T et al. Oxidation parameters in complete correction of renal anemia. Clin Nephrol 2000; 53 [Suppl 1]: S30-S35
4. Weinstein T, Chagnac A, Korzets A et al. Haemolysis in haemodialysis patients: evidence for impaired defense mechanisms against oxidative stress. Nephrol Dial Transplant 2000; 15: 883-887
5. Gallucci MT, Lubrano R, Meloni C et al. Red blood cell membrane lipid peroxidation and resistance to erythropoietin therapy in hemodialysis patients. Clin Nephrol 1999; 52: 239-245
6. Takeuchi T, Nakajima M, Ohta Y et al. Evaluation of 8-hydroxydeoxyguanosine, a typical oxidative DNA damage, in human leukocytes. Carcinogenesis 1994; 15: 1519-1523
7. Tarng DC, Huang TP, Wei, YH et al. 8-Hydroxy-2′-deoxyguanosine of leukocyte DNA as a marker of oxidative stress in chronic hemodialysis patients. Am J Kidney Dis 2000; 36: 934-944
8. Tarng DC, Huang TP, Liu TY et al. Effect of vitamin-E-bounded membrane on the 8-hydroxy-2′-deoxyguanosine level in leukocyte DNA of hemodialysis patients. Kidney Int 2000; 58: 790-799
9. Tarng DC, Wen Chen T, Huang TP et al. Increased oxidative damage to peripheral blood leukocyte DNA in chronic peritoneal dialysis patients. J Am Soc Nephrol 2002; 13: 1321-1330
10. Bagdanov M, Brown RH, Matson W et al. Increased oxidative damage to DNA in ALS patients. Free Radical Biol Med 2000; 29: 652-658
11. Inoue T, Inoue K, Maeda H et al. Immunological response to oxidized LDL occurs in association with oxidative DNA damage independently of serum LDL concentrations in dyslipidemic patients. Clin Chim Acta 2001; 305: 115-121
12. Satoh M, Yamasaki Y, Nagake Y et al. Oxidative stress is induced by the long-term use of vitamin E-coated dialysis filter. Kidney Int 2001; 59: 1943-1950
13. Toyokuni S, Tanaka T, Hattori Y et al. Quantitative immunohistochemical determination of 8-hydroxy-2′-deoxyguanosine by a monoclonal antibody N45.1: its application to ferric nitrilotriacetate-induced renal carcinogenesis model. Lab Invest 1997; 76: 365-374
14. Kikuchi A, Takeda A, Onodera H et al. Systemic increase of oxidative nucleic acid damage in Parkinson's disease and multiple system atrophy. Neurobiol Dis 2002; 9: 244-248
15. Umegaki K, Hashimoto M, Yamasaki H et al. Docosahexaenoic acid supplementation-increased oxidative damage in bone marrow DNA in aged rats and its relation to antioxidant vitamins. Free Radical Res 2001; 34: 427-435
16. Uchida E, Morimoto K, Kawasaki N et al. Effect of active oxygen radicals on protein and carbohydrate moieties of recombinant human erythropoietin. Free Radical Res 1997; 27: 311-323
17. Nguyen-Khoa T, Massy ZA, De Bandt JP et al. Oxidative stress and haemodialysis: role of inflammation and duration of dialysis treatment. Nephrol Dial Transplant 2001; 16: 335-340
18. Handelman GJ, Walter MF, Adhikarla R et al. Elevated plasma F2-isoprostanes in patients on long-term hemodialysis. Kidney Int 2001; 59: 1960-1966
19. Spittle MA, Hoenich NA, Handelman GJ et al. Oxidative stress and inflammation in hemodialysis patients. Am J Kidney Dis 2002; 38: 1408-1413
20. Stenvinkel P, Holmberg I, Heimburger O, Diczfalusy U. A study of plasmalogen as an index of oxidative stress in patients with chronic renal failure. Evidence of increased oxidative stress in malnourished patients. Nephrol Dial Transplant 1998; 13: 2594-2600
21. Tarng DC, Tsai TJ, Chen WT et al. Effect of OGG1 1245C→G gene polymorphism on 8-hydroxy-2′-deoxyguanosine levels of leukocyte DNA among patients undergoing chronic hemodialysis. J Am Soc Nephrol 2001; 12: 2338-2347
22. Park KS, Kim JH, Kim MS et al. Effects of insulin and antioxidant on plasma 8-hydroxyguanosine and tissue 8-hydroxyguanosine in streptozotocin-induced diabetic rats. Diabetes 2001; 50: 2837-2841
23. Bagdanov MB, Beal MF, McCabe DR et al. A carbon column-based liquid chromatography electrochemical approach to routine 8-hydroxy-2′-deoxyguanosine measurements in urine and other biologic matrices: a one-year evaluation of methods. Free Radical Biol Med 1999; 27: 647-666
24. Kasai H. Analysis of a form of oxidative DNA damage, 8-hydroxy-2′-deoxyguanosine, as a marker of cellular oxidative stress during carcinogenesis. Mutat Res 1997; 387: 147-163